Mycurit 150 mg/75 mg Tablet
By Mycurit
Rx
10 Tablet in a Strip

Composition
Rifampicin(150mg) + Isoniazid(75mg)

Manufacturer - Cadila Pharmaceuticals Ltd
Sarkhej-Dholka Road, Bhat, Ahmedabad-382 210, INDIA.

Expires on or after
August, 2025
About Mycurit 150 mg/75 mg Tablet
Mycurit 150 mg/75 mg Tablet is a combination medicine primarily used for treating tuberculosis by inhibiting the growth of the microorganisms responsible for the infection. It is essential to emphasize that Mycurit 150 mg/75 mg Tablet is a prescription medication, and it should only be taken as directed by a healthcare professional. It is recommended to take the tablet on an empty stomach at a fixed time to maximize its effectiveness and avoid consuming more than the prescribed dose to prevent potential harm to the body.
Adherence to the prescribed treatment plan is crucial, even if symptoms improve, as interrupting the course prematurely may decrease the medicine's potency. Patience is key, as it may take some time for the medicine to manifest its effects on the symptoms. If any worsening of the condition or lack of improvement is noticed, consulting the doctor is highly advised for proper assessment and guidance.
As with any medication, Mycurit 150 mg/75 mg Tablet may cause some common side effects such as nausea, vomiting, fever, and changes in urine color. Managing these side effects by staying hydrated is recommended. If any side effects worsen, prompt medical consultation is necessary. Serious side effects are uncommon but require immediate medical attention, especially in cases of allergic reactions characterized by rashes, itching, or breathing difficulties.
Prior to initiating treatment with Mycurit 150 mg/75 mg Tablet, disclosing all current medications and pre-existing health conditions to the healthcare provider is crucial. Patients with liver or kidney issues should use this medicine cautiously under medical supervision. Pregnant or breastfeeding individuals should consult their doctor before taking this medication. Alcohol consumption should be avoided as it may intensify drowsiness. Although Mycurit 150 mg/75 mg Tablet generally does not impair driving ability, it is advisable to refrain from driving if it causes drowsiness or dizziness. Adequate rest and a nutritious diet are essential during treatment to facilitate a speedy recovery.
Throughout the treatment period, the doctor may recommend periodic laboratory and diagnostic tests to monitor the medicine's impact on the body. It is imperative to maintain open communication with the healthcare provider to ensure safe and effective treatment with Mycurit 150 mg/75 mg Tablet.
Disclaimer
The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.
₹33.11
Inclusive of all taxes